Jonathan Rubin
Supernus Pharmaceuticals, Inc. · Chief Medical Officer · Univeristy of Michigan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
7 more share only the name and are not shown
Trial papers
181
PubMed author-name match
Trials
Studies that name Jonathan Rubin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:19 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05097079 · Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric SubjectsSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · withdrawn · Sialorrhea · study director
- Ph4NCT04786990 · Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- Ph3NCT04143217 · Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder · study director
- Ph3NCT04016779 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- Ph3NCT03247543 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHDSupernus Pharmaceuticals, Inc. · completed · ADHD · study director
- Ph3NCT03247556 · Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHDSupernus Pharmaceuticals, Inc. · completed · ADHD · study director
- Ph3NCT02736656 · Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)Supernus Pharmaceuticals, Inc. · active not recruiting · Attention-Deficit/Hyperactivity Disorder · study director
- Ph3NCT02610868 · Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in AdultsSolstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC · completed · Sialorrhea · study director
- Ph3NCT01994109 · Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsSolstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC · completed · Sialorrhea · study director
- Ph1/Ph2NCT01107496 · Evaluation of Immediate-Release Viloxazine in Adults With ADHDSupernus Pharmaceuticals, Inc. · completed · Attention-Deficit/Hyperactivity Disorder (ADHD) · study director
- N/ANCT00847951 · Ultrasound for Perfusion in NeonatesUniversity of Michigan · withdrawn · Kidney Perfusion · principal investigator
- Early Ph1NCT00726947 · Ultrasound Elasticity Imaging of Venous ThrombiUniversity of Michigan · completed · Thrombosis · principal investigator
- Ph2NCT00515437 · A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease PatientsSolstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC · completed · Drooling · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Detection of Preeclampsia and Fetal Growth Restriction Based on Simultaneous Assessment of Maternal and Fetal Blood Flow ComponentsR01HD118657 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2026 · $598,644 awarded in 2026Same name and institution; not confirmed by an ID
- Assessment of Placental Blood Volume Flow and Function in IUGR Using a Transfer Function ModelR21HD095501 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2019 to 2020 · $234,000 awarded in 2020Same name and institution; not confirmed by an ID
- Ultrasound Elasticity Imaging in Breast Cancer ScreeningR21CA109440 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2005 to 2006 · $186,635 awarded in 2006Same name and institution; not confirmed by an ID
- Aging Venous Thrombi with Ultrasound Elasticity ImagingR01HL068658 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2002 to 2005 · $333,047 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:19 UTC. The ranking covers the 200 most relevant of 181 PubMed records, and a shared surname and initials can bring in a namesake. All 181 on PubMed
- 823 citationsRCR 23.8
- 629 citationsRCR 20.4
- High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.N Engl J Med · 1985439 citationsRCR 11.0
- Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.N Engl J Med · 1979435 citationsRCR 10.4
- Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.J Clin Oncol · 2004422 citationsRCR 13.3
- 356 citationsRCR 10.6
- Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.Arch Surg · 1990340 citationsRCR 14.9
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.Lancet Oncol · 2010326 citationsRCR 8.5
- Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.J Clin Oncol · 1998319 citationsRCR 7.6
- Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.N Engl J Med · 1981296 citationsRCR 7.8